AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Tubacex S.A.

Investor Presentation Apr 20, 2020

1891_rns_2020-04-20_42557908-5775-4088-a062-41d69163b3c5.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

CORPORATE PRESENTATION April 2020

Index

  1. Current situation 2. Where was Tubacex 3. Future prospects 4. Tubacex Share

Current situation 1

Covid-19 Status

TUBACEX
GROUP
TUBACEX Special
Components
steel and
Extrusion
I u bace X
Asia
l u Dacex
America
Advanced
Solutions
Corporate
Office
Num 0/0 Num 0/0 Num 0/0 Num 0/0 Num 0/0 Num 0/0 Num 0/0
1
Gile
Total Headcount
Heads not FTEs
2573 639 1339 205 172 154 64
Confirmed Infected
COVID-19
2 0% 0% 0% O O 0 0
Mandatory
Quarantine
511 20/0 17 3% 31 2% 0 O 0 B 5%
201 Sick
no COVID-19
118 5% 17 3% 95 7% O 1 1% 4 3% 1 2%
1 Vacation
Temporary leaves
204 8% 72 11% 79 6% 3 1% 0 12 8% 38 60%
Smart
Working
279 11% 66 10% 70 5% 69 34% 21 12% 30 19% 23 37%
Last complete update 09 - 13 APR 24-mar - 1-apr 30-mar 06-08 APR 25-mar - 1-apr 01-apr - 06-apr
Employees Health and Safety Measures *
Transmission Risk
Minimization
94% O 92% ● 94% ● 94% ● 98% ● 100% ● 88%
Support to affected
100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
96% 95% ● 100% ● 100% 0 33% 97% ● : 00%

Currently 2 confirmed cases so far, and 52 quarantined. No confirmed cases in Spain Protocols and measures adopted have helped the minimization of the transmission

Plant situation

Plant situation
Plant Status
Spain Working normally until Tuesday 17th
of March

Stoppage due to union's pressure from 18th
March to 22nd

March when we re-started reducing shifts
Stoppage after Royal Decree from 30th
March to April 9th

when we reopen thanks to the explanatory notes with 1 shift
Restarting of the normal activity on April 14th

until end of month. From May onwards expected reduction in workforce
Italy
Plants were open and working but with slowdown in production until 26th
March, with reduction of shifts
From Thursday 26th
of March and until at least 3rd

of April, Italy plants needed to be shut down after Italian Government
decision
Reopening of one of the two mills on 31st

March after an approved application made to Government, but at minimum
production level (at least until 3rd
May)
Middle
East &
Norway

Working at limited level of activity in Norway, UAE and Saudi because of some workers absence and restrictions.

Major concern is UAE and government measures, although we have been classified as essential industry
Austria
Working at 70% of production approximately

Reduction of personnel working for health and safety reasons
Asia Tubacex India working normally until March 24th. Complete shutdown until 3rd

May

Level of reported cases still zero or low in the regions we operate in India. In case the situation deteriorate the team at
Mumbai office will work from home .

China & Singapore since January have been working from home .
USA
Both US plants still working, although with low volume

US government has classified, at list per now, our business as essential because of our sales to aerospace/defense
Service
centers

Overall activity is slowing down, and the order intake is experiencing a slowdown

Major risk related with borders closing. Deliveries from TSS central.
Overall orders slowdown during this period. Production at around 50% in March

Financial Markets situation (1/2)

  • During the last weeks we have lived moments of maximum volatility and uncertainty on the markets The fast spread of COVID-19 worldwide and its economic consequences fed investors' risk aversion, causing unprecedent falls in the stock exchanges

Source: Caixabank Research

Source: Caixabank Research

Current Situation

Financial Markets situation (2/2)

  • Investors have not found comfort on the bond markets, very pressed by the fiscal stimulus
  • announced and the current desire of liquidity Risk premiums, not only the corporate ones but also the sovereign ones, have increased until very
  • high levels, what could distort the transmission of the monetary policy in Europe Additionally the oil war between Saudi Arabia and Russia has led to a drop of close to 60% in the brent barrel price year-to-date, affecting even more negatively to companies related to the energy sector In this situation the new base scenario for 2020 is a global recession with an expected global GDP of 0.9% vs. 3.2% expected at 2019 year-end

Oil Market situation

  • The current situation effects on oil demand and the global economy, throws many projects into
  • doubt when will be sanctioned Companies have already started reducing their annual capital spending for 2020 by more than 25% in recent financial updates, although improving in the upcoming years

Taken Actions - Summary Tubacex Group Crisis Committee cross-functional team created to ensure clear execution, coordinate and communicate the contingency plan with focus on the following 4 workstreams

Current Situation
Tubacex Group Crisis Committee cross-functional team created to ensure clear execution,
coordinate and communicate the contingency
workstreams plan with focus on the following 4
HEALTH & SAFETY BUSINESS CONTINUITY FINANCIAL RESILIENCE COMMERCIAL FOCUS
1.
Hygiene & cleaning
1.
Key products &
services
1.
Scenario based
stress tests
1.
Cash collection
2.
Travel restrictions
2.
Supply Chain
Stabilization
2.
Ensure liquidity/
Cash management
2.
Contractual
coverage, avoid
penalties
3.
Facility and on-site
guidelines
3.
Human Resources
3.
Cost control,
specific plan
2.
Analyze short term
opportunities
4.
Communication
4.
Analyze legal
implications
4.
Communication to
customers
5.
Reduction of fixed
cost

Taken Actions – Health & Safety

We have communicated personal hygiene good practices.
--- ------------------------------------------------------- --
  • Hygiene & We have increased cleaning protocols frequency.
  • cleaning Disinfectants.
    • Specific protocols in the factories.
  • Separation Working with protection and physical separation in office spaces, production plants, dining rooms (some closure), etc.
    • Restriction for meetings and boost the use of Microsoft Teams.
  • Travel
  • Restriction to travel and customer visits since end of February.
  • restrictions Stop travelling since March.
    -
  • Split between key teams per function area.
  • Home office Home office has been proactively recommended to personnel that can work from home.

Constant and continuous proactive communication with our employees.

    • Communication Global guideline created for covid-19.
      - Created a safe channel for employees to notify company about an infection.
      - Management of stress and rumors through each Business Unit Director.

Taken Actions – Business Continuity

  • Products & Services
  • Analysis of critical products and services implementing corrective actions:
    • Secure necessary stocks.

Advance delivery of planned orders.

Development of alternative suppliers.

Validate substitutive products and manufacturing routes.

Balance risk in collaboration with other business units.

supplier considering country/regions situation.

Current orders

Suppliers

Evaluation of existing contracts and commitments with suppliers for a potential temporary interruption of operations.

Assess the criticality of the supplier service or materials, based on impact on production, considering current and project demand and existing stocks.

Estimate the probability of SC disruptions based on location and activity of

  • Define actions to activate Force majeure clauses and reduce risk exposure.
  • Identification of key personnel and backup plans.
  • Human Resources Legal labor actions scenarios analysis on going for each area with HR in order to ensure coordinated actions.
    • Financial and operations impact have been considered.

Current Situation
Taken Actions –
Financial Resilience
Scenario based
stress test

Conduct Stress test scenarios for our economic cost structure in case of
stoppage or interruption of the activity. Best, Base and Worst cases.
Cash and
liquidity
management

Cash management action plan in place to maximize cash position.

Management of maturities of all our financing and debt issues in the short and
long term.

Maturities and actions with private, public banks, regional and national
governments with their different entities.
Cost control
Ensure cost control, transition of fixed cost to variable cost as much as possible.

Stoppage of capital expenditures.
Legal
Analyze current legal situation of our contracts and different cases for contracts
with insurance companies in view of potential stops, losses, etc. in an
extraordinary situation .
Fixed cost
reduction

Application of different measures in different scenarios.

Specific plan for fixed costs reduction.

Apply temporary employment regulation with Public support.

Taken Actions – Commercial focus

Cash collection
Proactive collection management, main priority.

Management of defaults with customers.
Contracts
coverage

Force majeure coverage in contracts being proactively analyzed with
customers in a very positive way.
Multiannual
contracts

Large multiannual contracts still in effect today, last conversations with
customers confirm the contract

Important contracts to be sign in short time.
Short-term
opportunities

Order Intake clearly reduced, projects postponed, some cancelations…

No clear visibility of the consequences regarding market volume and price.

Close urgently orders under negotiation.
Customer
communication

Formal feedback to customers regarding our operations status already
provided.

Provided efficient communication with customers.

2

Where was Tubacex?

  • Before Covid-19 Sales evolution Global investment in Upstream The dramatic crisis in the Oil sector characterized by an unprecedent fall in Upstream Capex affected Tubacex's revenues
  • However, the correct positioning in premium products allowed the Group to increase revenues in 2018 -2019

market

New perimeter investing in 9 productive mills with potential revenues of approx. €300M and with a positioning focused on complete solutions

So now, we are better positioned for the recovery

Where was Tubacex?
So now, we are better positioned for the recovery
Pre Crisis
2014 (Proforma)
Crisis
2016 -
2017
Recovery
2018 -
2019
Change
Revenues 750 M€ 500 M€ 677 M€ +177 M€ (+35%)
Gross margin 370 M€ (50%) 230 M€ (46%) 320 M€ (47%) +90 M€ (+36%)
EBITDA 82 M€ (12%) 35 M€ (7%) 70 M€ (10%) +35
M€ (+100%)
Headcount 2.800 2.314 ~2.600 +286 p.
# Patents 0 7 8 +1
Order
Intake
≈ 700 M€ ≈ 1.000 M€ 500 M€ -500 M (-50%)*
% Premium
Product
40% 65% 73%
8%
Sales to End User
/ EPC
35% 65% 50%
30%

Loss of volume and reduction in prices not offset by cost reduction measures

Where was Tubacex?
Getting closer to our previous Strategic Target
Starting
point
Improvement Oil&Gas
Crisis
Recovery Strategic
Target
FY 2012 2013-2014 2015-2017 2018 -
2019
2020 -
2021
Product Mix (%
premium over sales)
27% 36.2% Premium
Products
60% Premium
Products
70% Premium
Products
70% Premium
Sales n.a. +15% -30% 700-800M€ 1,000M€
EBITDA Margin 8.6% 11.7% 7-8% 12% 13-15%
Net Debt / EBITDA 5.7x 2.4x >3x <3x <3x
RoCE 5.2% 10% <1% 10% >10%
Working Capital /
Sales
55.3% 37% 40% 35% 35%

Before covid-19 we were aligned with market consensus for FY20

Main relevant projects under discussion

We are now better positioned for large frame agreements in different products

Focused on long term agreements

I+D – we have bet heavily in Innovation and we have a large backlog of projects: Tubacoat example An R&D effort that has become a reality with a successful go-to-market strategy

The technology is being widely accepted with orders already invoiced, trials and testing being done by most of the main refining companies in the world

3

Social support (1/2)

We have created a supply management team based on our international structure and related companies Purchasing of material and distribution to a "maker group" to produce and distribute masks produced by 3D printers We have bought more than 500k masks that we are distributing mainly at nursing homes in the Basque Country

Protective

  • mask 10,000 protective masks

Regular masks

PPE

PPE We have bought and currently delivering other types of Personal Protective Equipment such us boiler suits, coats, globes, thermometers, etc.

Social support (2/2)

  • To use our installations to storage and manage all kind of material To use our medical service infrastructure in Llodio and Amurrio in order to realize rapid tests to population

CASH MANAGEMENT DEFENSIVE TOOLS:

  • Diversified and resilient financial structure (public and private financing facilities, bilateral structure, main banks compromised to renew short-term revolving lines, etc) Year 2020 – Summary of actions
    • Starting point of 140M€ of cash at the end of February proof of our financial strength
    • Even under COVID crisis the effect on cash of our "stress test in operations" including collections, payments and capex disbursements shows that the financial structure of the company withstands the current situation
    • Important cost reduction at all levels:
      • − Salary reductions:
        • − Management Committee & Board: 30%
        • − Other groups and executives: 10%-30%
      • − Stoppage of non-strategic investments
  • − Non-essential costs removal
  • − Fixed costs reduction
  • − Job regulation measures (i.e. ERTEs) analysis according to current regulation
    • To keep current financial sources: renewing/substituting credit lines and activating all the cash management defensive tools available, including Public supported measures
    • Don't burn cash at operating level despite the current situation
    • Don't stop strategic projects
    • To complete multiannual contracts with customers and significant orders
    • Big uncertainty in real effects depending on the duration of the pandemic

Our main target is to maintain neutral cashflow

Future…

It is to early to forecast possible scenarios for the upcoming years, but it is important to highlight that our market positioning has significantly improved in the last years and that we have an experienced team that has already overcome different crisis periods:

Frame Agreements Success

Frame Agreements Success
Customer
Status
Customer 1
Pending
Customer 2
Signed
Customer 3
Signed
Customer 4
Signed
Customer 5
Signed
Customer 6
Pending
Customer 7
Signed
Customer 8
Signed
Customer 9
Pending
Customer 10
Signed
Customer 11
Pending
Customer 11
Pending
Customer 12
Signed

Objective to sign over 15frame agreements in 2019-2020

Objective to sign multiannual contracts for over 1.000M€ value for the next 4-5 years.

Stronger market positioning oriented to long-term agreements Offering a complete solution gives us a competitive advantage vs other players

Possible scenarios of recovery

Tubacex share in 2020

Tubacex share Price (€/share)

Tubacex vs. other players in 2020

Stock Market evolution

Tubacex vs. other players in March & April 2020

Corporate Presentation 2020 33

Buy back Program – Goal and detail

  • a Buy Back Program Main characteristics:
  • -
    -
    -
    -
Tubacex Share
Data Acquired shares Average price Investment (€) % share capital
On
12nd
March
at
Market
closing
# Accumulated €/share accumulated
suspension
of
liquidity
program
is
13/03/2020 69.450 69.450 1,4722 102.248 0,1%
announced
due
to
the
beginning
of
16/03/2020 85.145 154.595 1,3509 115.022 0,1%
a
Buy
Back
Program
17/03/2020 77.590 232.185 1,4049 109.006 0,2%
18/03/2020 73.340 305.525 1,4358 105.302 0,2%
19/03/2020 88.970 394.495 1,3023 115.866 0,3%

Main
characteristics:
20/03/2020 93.644 488.139 1,3010 121.831 0,4%
23/03/2020 89.551 577.690 1,2660 113.372 0,4%

Destinated
funds:
6M€
24/03/2020 89.985 667.675 1,2822 115.379 0,5%
25/03/2020 98.018 765.693 1,2820 125.659 0,6%

Objective:
amortization
26/03/2020 93.180 858.873 1,2813 119.392 0,6%
27/03/2020 96.692 955.565 1,2952 125.235 0,7%

Duration:
6
months
30/03/2020 84.671 1.040.236 1,2627 106.914 0,8%

Financial
broker:
JB
Capital
31/03/2020 78.746 1.118.982 1,2842 101.126 0,8%
01/04/2020
02/04/2020
75.100
47.212
1.194.082
1.241.294
1,2634
1,2658
94.881
59.761
0,9%
0,9%
03/04/2020 38.000 1.279.294 1,3060 49.628 1,0%
06/04/2020 28.397 1.307.691 1,3929 39.554 1,0%
07/04/2020 43.218 1.350.909 1,4680 63.444 1,0%
08/04/2020 54.157 1.405.066 1,4576 78.939 1,1%
09/04/2020 61.000 1.466.066 1,4520 88.572 1,1%
14/04/2020 25.080 1.491.146 1,4400 36.115 1,1%
1.987.245 1,1%

Talk to a Data Expert

Have a question? We'll get back to you promptly.